Cameroon’s National Strategic Plan for Health Research for 2026–2030 is budgeted at CFAF 3.044 billion, including CFAF 711.2 million—just over 23%—for ethics committees and bioethical monitoring and regulation. Governance and ethics represent the plan’s largest spending area at CFAF 978.2 million. Other allocations cover capacity building, financing, and the production and use of scientific results. The plan includes CFAF 511 million for decentralizing research across the country’s ten regions, but its average annual spending of CFAF 608.7 million is far below the level implied by the 2% research-financing target in the 2008 Algiers Declaration. The document describes the budget as a coordination and structuring foundation rather than the full national research budget, and identifies dependence on external funding and possible budget execution failures as major implementation risks.

Yaoundé General Hospital has awarded ETS ALIBA two contracts worth a combined 98.6 million CFA francs for information technology equipment and the installation of 200 surveillance cameras. The 73.9 million CFAF IT lot includes 40 desktop computers, five laptops, servers, network equipment, software licenses and a 64-terabyte backup system, while the 24.7 million CFAF surveillance lot includes cameras, cabling, network switches, recorders, storage drives and an 86-inch monitoring screen. The total is 1.4 million CFAF below the initial estimate of 100 million CFAF. The procurement documents do not identify the areas to be monitored, data-retention period or authorized viewers, and do not disclose the number or pricing of competing bids, limiting assessment of competition and oversight. Delivery and installation are expected within two months.

Researchers detected the blaOXA-181 carbapenem-resistance gene in one Escherichia coli isolate from a hospitalized patient in Douala, reportedly the first known detection in Cameroon. The finding is preliminary: only four blood isolates were deeply sequenced, and the samples were collected between June 2022 and May 2023. The wider study found multidrug-resistant E. coli among healthy pregnant women, market chickens and wastewater, with high resistance to ciprofloxacin and trimethoprim/sulfamethoxazole, and identified 45 resistance genes among 32 sequenced bacteria, including mcr-1 associated with colistin resistance. Related bacterial families appeared across human, animal and environmental samples, supporting a One Health surveillance approach, but the study does not establish direct transmission or nationwide prevalence. Further monitoring is needed to determine whether blaOXA-181 has spread since 2023.

A six‑year study by the Centre Pasteur du Cameroun and the University of Yaoundé I found that more than a third of alcoholic beverages sold in Yaoundé exceed European methanol limits, with particularly high levels in some spirits and wines. Local traditional drinks show lower concentrations but still surpass Nigerian standards, undermining export potential. Labeling irregularities, nonexistent traceability, and widespread quality‑control failures indicate systemic fraud risks and a lack of regulatory oversight. Chronic methanol exposure poses significant neurological and visual health threats in a country with extremely high alcohol consumption. Cameroon lacks national methanol standards, leaving consumers exposed and enabling unsafe production practices. The findings call for urgent regulatory reform and alignment with international norms to prevent a growing public health burden.

A state‑backed loan of 15 billion FCFA from Standard Chartered Bank, guaranteed by UK Export Finance, will fund the reconstruction of Jamot Hospital in Yaoundé and the construction of a new psychiatric hospital in Mfou. The project aims to improve care in pneumology and mental health, reduce costly medical evacuations abroad and create about 1,000 jobs. While aligned with Cameroon’s national development strategy, concerns persist regarding the unclear project timeline, fund allocation, access for vulnerable populations and the country’s rising debt level. Daniel Ekoua has been appointed to lead Jamot’s modernization, though his nomination has stirred debate. Despite uncertainties, the initiative represents significant progress in addressing specialized healthcare needs in Cameroon.

Cameroon must raise 26 billion FCFA annually from 2026 to replace declining Gavi funding and prevent major setbacks in routine vaccination coverage. The Programme Élargi de Vaccination relies heavily on external support that will end in 2027, forcing a rapid shift to domestic financing despite limited national health budgets. The Service d’appui aux initiatives locales de développement is pushing for government commitments through advocacy involving civil society and media, but authorities have not yet responded as concerns grow over the country’s ability to secure vaccine sovereignty.

Drug use in Cameroon has surged, with more than 2,000 cases recorded in 2024, more than double the previous year. Cannabis is the most consumed substance, followed by tobacco, tramadol and alcohol, with synthetic and emerging local drugs also rising. Factors driving the increase include socioeconomic precarity, youth unemployment, peer pressure and growing psychological distress. The government is responding through prevention, risk reduction and expanded care, supported by a new national strategic plan for 2024–2030, but resources remain insufficient to meet the scale of the crisis. The rapid rise in cases and the vulnerability of young people highlight the need for more systemic and intensive public health, education and security measures.

The Global Fund reduced Cameroon’s 2023–2025 health grant by 10 percent, withdrawing nearly 17 billion CFA francs due to governance lapses, mismanagement of allocated funds and failure to provide counterpart financing. The malaria program faces the largest reduction. Authorities have until mid-July 2025 to respond or the cuts become final. Previously suspended activities remain frozen. Sources within the health sector note the decision could have been avoided with stronger reforms and better anticipation, including legislative action on universal health coverage and improved social-sector budgeting. The cut is expected to jeopardize national HIV, malaria and tuberculosis programs, potentially increasing disease incidence and forcing emergency restructuring. The decision signals declining donor confidence and pressures the government to strengthen transparency, financial traceability and governance to avoid further disengagement from international partners.

Leaders of two major Cameroonian hospitals, Emile Mboudou and Arthur Essomba, appeared before the Audit Court over alleged mismanagement during their respective tenures. Judges reviewed administrative and financial oversight from 2015 to 2021, with a verdict expected in July 2025. While both provided justifications, detailed allegations were not disclosed. The Yaoundé University Hospital faced severe deterioration, salary delays, strikes, reduced patient numbers and a sharp drop in revenue during the assessed period. Supporters attribute the failures to limited budgets and structural constraints rather than mismanagement.

The deaths of journalist Bibi Ngota and the disappearance of Vanessa Tchatchou’s baby remain emblematic of government mishandling and insensitivity, centered on statements made by government spokesperson Issa Tchiroma Bakary that violated medical confidentiality and dismissed public outcry. His current presidential bid and promises of a humane health system clash with his controversial record, raising doubts about the credibility of his reformist stance and the sincerity of his new focus on dignity and public care.